.Welcome to this week's Chutes & Ladders, our roundup of substantial management hirings, shooting...
.After exposing plannings to attack the U.S. social markets less than a month earlier, Zenas Biophar...
.Psyence Biomedical is spending $500,000 in portions to acquire fellow psilocybin-based biotech Clai...
.Five months after approving Energy Therapies' Pivya as the initial new treatment for straightforwar...
.Eli Lilly has actually vaulted into an AI-enabled medicine breakthrough bargain, partnering along w...
.Lykos CEO and creator Amy Emerson is actually leaving, with main working police officer Michael Mul...
.Novartis levels a new frontier in its collaboration along with Voyager Rehabs, paying $15 million t...
.On the heels of an FDA rejection for its own primary rival Novo Nordisk, Eli Lilly is actually gain...
.Only a few months after dosing the 1st client in a phase 2 trial for recently diagnosed glioblastom...
.Eli Lilly's hunt for weight problems targets has led it to the dark genome. The Big Pharma has put ...